Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Kezar Life Sciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 127 | 132 | +5 |
| Shares | 54.9M | 57.5M | +2.64M (+4.8%) |
| Value | $454.0M | $495.5M | +$41.5M (+9.1%) |
New holders (25)
Institutions that held Kezar Life Sciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (20)
Institutions that held Kezar Life Sciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,608,400 | $13.3M |
| Deerfield Management Company, L.P. (Series C) | 1,419,000 | $11.7M |
| Cormorant Asset Management, LP | 1,200,000 | $9.92M |
| Soleus Capital Management, L.P. | 252,000 | $2.08M |
| Occudo Quantitative Strategies LP | 94,062 | $778.0K |
| Acadian Asset Management LLC | 84,584 | $700.0K |
| HAP Trading, LLC | 79,215 | $655.0K |
| Cinctive Capital Management LP | 40,000 | $331.0K |
| Squarepoint Ops LLC | 39,005 | $323.0K |
| Walleye Trading LLC | 38,490 | $318.0K |
| HRT Financial LP | 32,449 | $268.0K |
| Bridgeway Capital Management, LLC | 27,200 | $225.0K |
| Ellsworth Advisors, LLC | 25,840 | $214.0K |
| Harvest Investment Services, LLC | 24,022 | $198.0K |
| Ergoteles LLC | 17,300 | $143.0K |
| Voloridge Investment Management, LLC | 16,611 | $137.0K |
| Jefferies Group LLC | 10,000 | $82.7K |
| Point72 Hong Kong Ltd | 1,009 | $8.00K |
| Captrust Financial Advisors | 33 | $0 |
| Ellevest, Inc. | 51 | $0 |